The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.
about
BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteinsDimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3)Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleusRegulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa BThe bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent mannerNF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like moleculeA new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcriptionRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsControl of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alphaTransdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplicationSCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinaseThe Ubiquitination of NF-κB Subunits in the Control of TranscriptionKBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cellsGenome-wide association study of treatment refractory schizophrenia in Han ChineseDNA binding alters the protease susceptibility of the p50 subunit of NF-kappa B.Exclusion of NFAT5 from mitotic chromatin resets its nucleo-cytoplasmic distribution in interphase.Controlling for gene expression changes in transcription factor protein networks.Nuclear localization of IkappaB alpha is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats define a novel class of cis-acting nuclear import sequences.Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation.The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.Nfkb1 inhibits LPS-induced IFN-β and IL-12 p40 production in macrophages by distinct mechanisms.The Nfkb1 and Nfkb2 proteins p105 and p100 function as the core of high-molecular-weight heterogeneous complexes.Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.Alternative splicing of RNA transcripts encoded by the murine p105 NF-kappa B gene generates I kappa B gamma isoforms with different inhibitory activities.NF-κB-Mediated Regulation of OsteoclastogenesisFunctions of NF-kappaB1 and NF-kappaB2 in immune cell biologyThe relocalization of v-Rel from the nucleus to the cytoplasm coincides with induction of expression of Ikba and nfkb1 and stabilization of I kappa B-alpha.Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters.Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammationInducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B.Differential regulation of NF-kappaB2(p100) processing and control by amino-terminal sequences.Viral induction of the human beta interferon promoter: modulation of transcription by NF-kappa B/rel proteins and interferon regulatory factorsTransformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids.Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines.Alternate RNA splicing of murine nfkb1 generates a nuclear isoform of the p50 precursor NF-kappa B1 that can function as a transactivator of NF-kappa B-regulated transcription.Functions of nuclear factor kappaB in bone.Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.
P2860
Q24315909-4CE0C3EA-76B9-4EC9-922C-7BD95EFA3799Q24321796-720D5CF0-DC90-444B-956C-115E2053F8B7Q24337591-5237EAF7-3264-4EA4-9D3F-E8933C8A8271Q24532251-AE68F058-DAE0-432C-8405-5FC0ABFF21FBQ24564833-8A8D18CC-9966-407A-B71F-A18B8C2A1758Q24604635-DDECA9E1-0AB3-4E55-9900-6DC7CED9F4E2Q24629772-EB251229-2C29-49F2-9471-3C1965B8F618Q24644412-F4850F08-E568-4CF4-8086-06F3E70CC853Q24651506-BE30C532-AAF8-4B15-8FC1-424E788E462DQ24676497-20BD60A1-211B-4851-A183-CF4D45051EF6Q24681560-355208E6-A76B-4CB2-AFD9-B703AA5207D9Q24685556-B97F97D2-E0D2-4599-A630-EB62050980BBQ26748938-9C65E5A0-A831-409B-9D14-BED99E2C9499Q28269339-4C4A81F3-6C74-40EB-B906-0F22EDD599C6Q28943538-48C2239E-D7C1-4121-9EDC-176E76F0C256Q30421431-6EDA9299-4661-4881-BF0F-0CDF55B101F2Q33502710-D4578E29-5859-40D1-A70A-35678DC42ECCQ33718721-41CFE58E-2F47-48FF-8DF4-37306B9DCF8DQ33786457-5559B2CB-26C4-4098-BBE9-C27EF1A8E17BQ33995197-B8F215DE-7F29-4C04-AE6E-C1CD653104C9Q34050744-DF5FF4C3-B2C9-478A-8EE5-4A31609F53EDQ34061332-A75EC68D-8D8A-417C-85F5-94D8B30E5581Q34200078-A4E1BCD1-A414-4C8D-B4BC-32A0A1481604Q34206845-7E42576E-3AF6-4302-BE33-4B4823647F63Q35019615-585328F5-507C-4612-A720-EA7E5311F619Q35150453-C6373FD2-7D47-499A-8148-333D5889C125Q35230057-FC811741-B948-4B99-873A-4551DA2B6AD1Q35260971-C62D1557-7A58-43D6-A6B6-24512DBCC332Q35815962-C4738168-208A-438F-B6A5-8EB73221DB8CQ35829918-ACD9139F-B64D-4D2D-95F4-9816C5903078Q35845633-A5407674-F93B-4345-87E8-F379BEB599E6Q36401739-FD913267-A2E5-4E24-A576-3F5CDFEDD362Q36551014-273AE6AB-C4A7-4FD5-942C-42BFD7181F48Q36563704-60307AC7-16E1-42D2-A744-034664017556Q36623607-9AD7513E-D29F-4C4A-81D4-B6DBBABDB91BQ36631040-40086D48-990B-4663-A678-E1AE478F8B32Q36652709-162C07DC-F241-4990-971E-FA2523FDE866Q36673048-A3F1656D-F662-423D-9B5F-3665E1772966Q37730952-442642DD-CB27-412B-A665-432C567F3FDEQ38315849-89AFB252-48AC-4128-AA05-84F100766C8C
P2860
The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.
description
1992 nî lūn-bûn
@nan
1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
name
The NF-kappa B p50 precursor, ...... t preferentially inhibits p50.
@ast
The NF-kappa B p50 precursor, ...... t preferentially inhibits p50.
@en
type
label
The NF-kappa B p50 precursor, ...... t preferentially inhibits p50.
@ast
The NF-kappa B p50 precursor, ...... t preferentially inhibits p50.
@en
prefLabel
The NF-kappa B p50 precursor, ...... t preferentially inhibits p50.
@ast
The NF-kappa B p50 precursor, ...... t preferentially inhibits p50.
@en
P2093
P2860
P1433
P1476
The NF-kappa B p50 precursor, ...... t preferentially inhibits p50.
@en
P2093
P2860
P304
P407
P577
1992-08-01T00:00:00Z